Anteris Technologies Submits Confidential Draft Registration Statement For Proposed US IPO

2024-08-05 1470
(fxcue news) - Biotechnology company Anteris Technologies Ltd. (AVR) said Tuesday it has submitted a confidential draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission by its affiliate, Anteris Technologies Global Corp., relating to the proposed U.S. initial public offering by Anteris Global of its shares of common stock. The number of shares of common stock to be offered and the price range for the offering have not been determined. The offering is expected to occur after the SEC completes its review process, subject to market and other conditions.
Sign In via X Google Sign In via Google
This page link:http://www.fxcue.com/56906.html
Tips:This page came from Internet, which is not standing for FXCUE opinions of this website.
Statement:Contact us if the content violates the law or your rights

Please sign in

关注我们的公众号

微信公众号